cURL Error: Failed to connect to 217.15.170.3 port 80 after 1059 ms: Couldn't connect to server Monitoring of AMGN situation on December 13, 2025
Stocks Prognosis
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site

Amgen's Improving Balance Sheet Signals Potential Buy Opportunity

Published on December 13, 2025
Amgen Inc. (AMGN) has been gaining positive attention from analysts lately, with BMO Capital raising its price target due to the strong outlook for its MariTide platform. Additionally, Wells Fargo maintains its Equal-Weight recommendation for the company, noting the potential for growth. Bank of Nova Scotia has also shown confidence in Amgen, holding a significant stake in the company. With the balance sheet continuing to improve, experts are considering Amgen a potential buy opportunity. For more insights on the movement of Amgen's stock, consult the professionals at Stocks Prognosis.
Go to AMGN Page

Investor opinions & comments

To leave a comment, you need to Login or Register.

There are no comments yet. Be the first to leave one!

Other Data for AMGN

Amgens NASDAQ:AMGN Shareholders Will Receive A Bigger Dividend Than Last Year

January 27, 2026

Amgen Inc. NASDAQ:AMGN Shares Could Be 49 Below Their Intrinsic Value Estimate Yahoo Finance

January 18, 2026

Amgen Inc. NASDAQ:AMGN Shares Unloaded by Rep. Jefferson Shreve

July 30, 2025

Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025

April 22, 2025

Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy

March 20, 2025

Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market

March 19, 2025

Related Data

Amgen Inc. AMGN Sees Significant Drop in Short Interest

November 22, 2024

Amgen Inc. AMGN Shows Strong Growth Potential Despite Earnings Decline

November 21, 2024

Amgen Inc. AMGN: A Trending Stock with Promising Returns

December 14, 2024

Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy

March 20, 2025

Amgen Inc. Continues to Attract Investors: Promising Outlook for AMGN

December 26, 2024